Patents by Inventor Klaus Brendel

Klaus Brendel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Radar frequency transparent effect pigment mixture, formulations and coatings thereof
    Patent number: 11958979
    Abstract: This invention deals with effect pigment mixture comprising platelet-like aluminum effect pigments obtained by grinding of aluminum or aluminum based alloy shot and silvery pearlescent pigments, wherein the silvery pearlescent pigments are taken from the group consisting of: a) pearlescent pigments comprising a transparent substrate which is coated with a high-refractive index layer with n>1.8, which comprises or consists of an iron-oxide with Fe(II)-ions, b) pearlescent pigments comprising a transparent substrate which is coated with a high-refractive index layer with n>1.8, which comprises or consists of titanium suboxide or a pearlescent pigment comprising a substrate with a high-refractive index with n>1.8 layer, which comprises or consists of a titanium suboxide that is optionally coated with a high-refractive index layer with n>1.8, c) pearlescent pigments comprising a transparent substrate which is coated with a high-refractive index layer with n>1.
    Type: Grant
    Filed: July 5, 2022
    Date of Patent: April 16, 2024
    Assignee: Eckart GmbH
    Inventors: Carolin Brendel, Klaus Greiwe, Robert Maul, Oliver Bedford, Gunter Kaupp
  • Substituted condensation products of N-benzyl-3-indenylacentamides with heterocyclic aldehydes for neoplasia
    Patent number: 6610854
    Abstract: Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes are useful for inducing or promoting apotosis and for arresting uncontrolled neoplastic cell proliferation, and are specifically useful in the arresting and treatment of neoplasias, including precancerous and cancerous lesions.
    Type: Grant
    Filed: July 26, 2002
    Date of Patent: August 26, 2003
    Assignees: Cell Pathways, Inc., University of Arizona
    Inventors: Gerhard J. Sperl, Paul Gross, Klaus Brendel, Gary A. Piazza, Rifat Pamukcu
  • Substituted condensation products of N-benzyl-3-indenylacent amides with heterocyclic aldehydes for neoplasia
    Publication number: 20030009033
    Abstract: Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes are useful for inducing or promoting apotosis and for arresting uncontrolled neoplastic cell proliferation, and are specifically useful in the arresting and treatment of neoplasias, including precancerous and cancerous lesions.
    Type: Application
    Filed: July 26, 2002
    Publication date: January 9, 2003
    Inventors: Gerhard J. Sperl, Paul Gross, Klaus Brendel, Gary A. Piazza, Rifat Pamukcu
  • Method for treating patients with neoplasia by administering substituted sulfonyl indenyl acetic and propionic acids and esters thereof
    Publication number: 20020107248
    Abstract: Substituted indenyl sulfonyl acetic acids are useful in the treatment of precancerous lesions.
    Type: Application
    Filed: December 28, 2001
    Publication date: August 8, 2002
    Inventors: Rifat Pamukcu, Klaus Brendel
  • Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes for neoplasia
    Patent number: 6426349
    Abstract: Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes are useful for inducing or promoting apotosis and for arresting uncontrolled neoplastic cell proliferation, and are specifically useful in the arresting and treatment of neoplasias, including precancerous and cancerous lesions.
    Type: Grant
    Filed: December 20, 2000
    Date of Patent: July 30, 2002
    Assignee: Cell Pathway and the University of Arizona
    Inventors: Gerhard J. Sperl, Paul Gross, Klaus Brendel, Gary A. Piazza, Rifat Pamukeu
  • Substituted benzylidene indenyl formamides, acetamides and propionamides
    Patent number: 6403831
    Abstract: Substituted benzylidene indenyl formamides, acetamides and propionamides are useful in the treatment of precancerous lesions and neoplasms.
    Type: Grant
    Filed: February 25, 2000
    Date of Patent: June 11, 2002
    Assignee: Cell Pathways, Inc.
    Inventors: Gerhard Sperl, Paul Gross, Klaus Brendel, Rifat Pamukcu, Gary A. Piazza
  • Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions
    Patent number: 6300346
    Abstract: Indenyl hydroxamic acids, (hydroxy) ureas and urethanes are useful in the treatment of precancerous lesions and neoplasms.
    Type: Grant
    Filed: March 7, 2000
    Date of Patent: October 9, 2001
    Assignee: Cell Pathways, Inc.
    Inventors: Gerhard Sperl, Paul Gross, Klaus Brendel, Rifat Pamukcu, Gary A. Piazza
  • Substituted condensation products of N-benzyl-3-idenylacetamides with heterocyclic aldehydes for neoplasia
    Patent number: 6166053
    Abstract: Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes are useful for inducing or promoting apotosis and for arresting uncontrolled neoplastic cell proliferation, and are specifically useful in the arresting and treatment of neoplasias, including precancerous and cancerous lesions.
    Type: Grant
    Filed: January 24, 2000
    Date of Patent: December 26, 2000
    Assignee: Cell Pathways, Inc.
    Inventors: Gerhard J. Sperl, Paul Gross, Klaus Brendel, Gary A. Piazza, Rifat Pamukcu
  • Substituted methoxy benzylidene indenyl acetic and propionic acids for treating patients with precancerous lesions
    Patent number: 6121321
    Abstract: Substituted methoxy benzylidene indenyl compounds are useful in the treatment of precancerous lesions and neoplasms.
    Type: Grant
    Filed: June 13, 1996
    Date of Patent: September 19, 2000
    Assignees: Cell Pathways, Inc., University of Arizona
    Inventors: Gerhard Sperl, Paul Gross, Klaus Brendel, Gary A. Piazza, Rifat Pamukcu
  • Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions
    Patent number: 6071934
    Abstract: Indenyl hydroxamic acids, (hydroxy) ureas and urethanes are useful in the treatment of precancerous lesions and neoplasms.
    Type: Grant
    Filed: March 25, 1997
    Date of Patent: June 6, 2000
    Assignee: Cell Pathways, Inc.
    Inventors: Gerhard Sperl, Paul Gross, Rifat Pamukcu, Klaus Brendel, Gary A. Piazza
  • Substituted condensation products of N-benzyl-3-indenylacetamides heterocyclic aldehydes for neoplasia
    Patent number: 6066634
    Abstract: Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes are useful for inducing or promoting apotosis and for arresting uncontrolled neoplastic cell proliferation, and are specifically useful in the arresting and treatment of neoplasias, including precancerous and cancerous lesions.
    Type: Grant
    Filed: December 7, 1998
    Date of Patent: May 23, 2000
    Assignees: Cell Pathways, Inc., University of Arizona
    Inventors: Gerhard J. Sperl, Paul Gross, Klaus Brendel, Gary A. Piazza, Rifat Pamukcu
  • Substituted benzylidene indenyl formamides, acetamides and propionamides
    Patent number: 6063818
    Abstract: Substituted benzylidene indenyl formamides, acetamides and propionamides are useful in the treatment of precancerous lesions and neoplasms.
    Type: Grant
    Filed: June 3, 1997
    Date of Patent: May 16, 2000
    Assignee: Cell Pathways Inc.
    Inventors: Gerhard Sperl, Paul Gross, Klaus Brendel, Rifat Pamukcu, Gary A. Piazza
  • Substituted condensation products of 1H-indenyl-hydroxyalkanes with aldehydes for neoplasia
    Patent number: 6028116
    Abstract: Substituted condensation products of 1H-indenylhydroxyalkanes with aldehydes are useful for inducing or promoting apoptosis and for arresting uncontrolled neoplastic cell proliferation, and are specifically useful in the arresting and treatment of neoplasia, including precancerous and cancerous lesions.
    Type: Grant
    Filed: April 3, 1998
    Date of Patent: February 22, 2000
    Assignee: Cell Pathways, Inc.
    Inventors: Gerhard Sperl, Paul Gross, Klaus Brendel, Gary Piazza, Rifat Pamukcu
  • Substituted methoxy benzylidene indenyl-acetic and propionic acids for treating patients with precancerous lesions
    Patent number: 5998477
    Abstract: Substituted methoxy benzylidene indenyl compounds are useful in the treatment of precancerous lesions and neoplasms.
    Type: Grant
    Filed: June 3, 1997
    Date of Patent: December 7, 1999
    Assignee: Cell Pathways Inc.
    Inventors: Gerhard Sperl, Paul Gross, Klaus Brendel, Gary Piazza, Rifat Pamukcu
  • Method for treating patients having precancerous lesions with substituted indene derivatives
    Patent number: 5965619
    Abstract: Substituted indene derivatives are useful for treating patients having precancerous lesions and for inhibiting the growth of neoplastic cells.
    Type: Grant
    Filed: December 23, 1997
    Date of Patent: October 12, 1999
    Assignee: Cell Pathways Inc.
    Inventors: Rifat Pamukcu, Gary A. Piazza, Paul Gross, Gerhard Sperl, Klaus Brendel
  • Substituted condensation products of n-benzyl-3-indenyl acetamides with heterocyclic aldehydes
    Patent number: 5948779
    Abstract: Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes are useful for inducing or promoting apotosis and for arresting uncontrolled neoplastic cell proliferation, and are specifically useful in the arresting and treatment of neoplasias, including precancerous and cancerous lesions.
    Type: Grant
    Filed: December 12, 1997
    Date of Patent: September 7, 1999
    Assignee: Cell Pathways, Inc.
    Inventors: Gerhard J. Sperl, Paul Gross, Klaus Brendel, Gary A. Piazza, Rifat Pamukcu
  • Lactone compounds for treating patient with precancerous lesions
    Patent number: 5776962
    Abstract: Substituted lactone compounds are useful in the treatment of precancerous lesions and neoplasms.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 7, 1998
    Assignees: Cell Pathways, Inc., University of Arizona
    Inventors: Paul Gross, Gerhard Sperl, Rifat Pamukcu, Klaus Brendel
  • Esters and amides of substituted pyrrole acetic acids
    Patent number: 5721347
    Abstract: Esters and amides of substituted pyrrole acetic acids are useful in the treatment of colonic polyps.
    Type: Grant
    Filed: June 16, 1995
    Date of Patent: February 24, 1998
    Assignees: Cell Pathways, Inc., University of Arizona
    Inventors: Paul Gross, Klaus Brendel, Rifat Pamukcu
  • Lactone compounds for treating patients with precancerous lesions
    Patent number: 5696159
    Abstract: Substituted lactone compounds are useful in the treatment of precancerous lesions.
    Type: Grant
    Filed: August 3, 1994
    Date of Patent: December 9, 1997
    Assignee: Cell Pathways, Inc.
    Inventors: Paul Gross, Gerhard Sperl, Rifat Pamukcu, Klaus Brendel
  • Esters and amides of substituted phenyl and pyridyl amino carboxylates
    Patent number: 5686589
    Abstract: Esters and amides of substituted phenyl and pyridyl amino carboxylates are useful in the treatment of colonic polyps.
    Type: Grant
    Filed: March 15, 1996
    Date of Patent: November 11, 1997
    Assignees: Cell Pathways, Inc., University of Arizona
    Inventors: Klaus Brendel, Paul Gross, Rifat Pamukcu